Showing 2,886 results

Filters Content type: News, Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Transgender people

Lenacapavir PrEP Does Not Interfere With Hormone Therapy for Trans People

Editor's pick
POZ
22 December 2025
PrEP policies & guidelines

MHRA approves lenacapavir for the prevention of sexually transmitted HIV-1 infection

Editor's pick
Medicines and Healthcare products Regulatory Agency (MHRA)
22 December 2025
Government, leadership & policy

Top 10 HIV Clinical Developments of 2025

Editor's pick
TheBodyPro
15 December 2025
PrEP programmes & uptake

TelePrEP Is on the Rise. Will It Transform HIV Prevention?

Editor's pick
TheBodyPro
15 December 2025
Vaginal rings & topical PrEP

Dapivirine Vaginal Ring price drops by over 50%, bringing more affordable HIV prevention options to women and adolescent girls in Africa and beyond

Editor's pick
Population Council
9 December 2025
PrEP policies & guidelines

South Africa wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

Editor's pick
Bhekisisa
8 December 2025
PrEP policies & guidelines

New Canadian HIV Guideline Emphasizes Patient Role in PrEP Decisions

Editor's pick
Medscape (requires free registration)
8 December 2025
PrEP science

Oral PrEP for HIV Starts Working Faster Than You Might Think

Editor's pick
TheBody
1 December 2025
PrEP policies & guidelines

Canada: New guideline on pre-exposure and postexposure HIV prevention

Editor's pick
EurekAlert!
1 December 2025
PrEP programmes & uptake

Drug vending machines revolutionise fight against HIV in Sao Paolo

Editor's pick
The Telegraph
26 November 2025
Government, leadership & policy

Exclusive: CDC to end all monkey research

Editor's pick
Science
24 November 2025
PrEP programmes & uptake

Current HIV ‘Risk Assessment’ Tools Fail to Address Populations Underserved by PrEP

Editor's pick
TheBodyPro
22 November 2025
PrEP programmes & uptake

How Europe's busiest PrEP clinics are simplifying care and reaching new populations

News
20 November 2025
PrEP programmes & uptake

Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible

News
17 November 2025
PrEP programmes & uptake

HIV PrEP and cisgender women: Are we meeting their needs?

Editor's pick
CATIE Blog
11 November 2025
Chemsex & recreational drug use

Chemsex use is changing in Europe

News
4 November 2025
Drug interactions & pharmacokinetics

No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy

Editor's pick
Contagion Live
3 November 2025
Injectable & long-acting PrEP

Gilead's long-acting PrEP Yeztugo takes off while cell therapy declines continue to haunt sales

Editor's pick
FiercePharma
3 November 2025
PrEP programmes & uptake

PrEP stigma undermines PMTCT efforts in Zimbabwe

Editor's pick
Be In The Know
30 October 2025
Treatment guidelines

New European HIV guidelines address sleep, obesity and breastfeeding

News
27 October 2025
PrEP policies & guidelines

Breakthrough HIV prevention jab given green light in South Africa

Editor's pick
Spotlight
27 October 2025
Injectable & long-acting PrEP

South African firms lose out on lenacapavir production

Editor's pick
Juta MedicalBrief
23 October 2025
Global health targets

More Europeans are dying from HIV now than 15 years ago

News
21 October 2025
Pharmaceutical industry

HIV Preventive Treatment Could Be Sold for One Thousandth of Current List Price

Editor's pick
Infectious Disease Society of America
21 October 2025